Burosumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Burosumab Usage And Synthesis

Uses

Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].

References

[1] Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children. Front Endocrinol (Lausanne). 2020 May 28;11:338. DOI:10.3389/fendo.2020.00338
[2] Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1. DOI:10.1007/s00198-022-06617-2

Burosumab(1610833-03-8)Related Product Information

• Manelimab
• Ponezumab
• Brentuximab
• Rolinsatamab
• Simtuzumab
• Nipocalimab
• Fulranumab
• Zolbetuximab
• Carlumab
• Belantamab